Robert J. Gibson serves as Executive at Scopus BioPharma Inc., where they oversee executive responsibilities. Since joining the company, Robert J. Gibson has executed 2 insider transactions totaling $2.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 25, 2021 involved purchasing 150 shares valued at $1.4K.
Robert J. Gibson currently holds 300 shares of Scopus BioPharma Inc. (SCPS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert J. Gibson has been a net buyer of SCPS stock. They have purchased $2.8K and sold $0 worth of shares.
Robert J. Gibson's most recent insider trade was on Feb 25, 2021, when they purchased 150 shares at $9.29 per share.
Get notified when new Form 4 filings are submitted
| $9.46 |
| Discretionary |